Efficacy and safety of vitamin K-antagonists (VKA) for atrial fibrillation in non-dialysis dependent chronic kidney disease.

Efficacy and safety of vitamin K-antagonists (VKA) for atrial fibrillation in non-dialysis dependent chronic kidney disease.

<h4>Background</h4>Essential information regarding efficacy and safety of vitamin K-antagonists (VKA) treatment for atrial fibrillation (AF) in non-dialysis dependent chronic kidney disease (CKD) is still lacking in current literature. The aim of our study was to compare the risks of str...

Full description

Bibliographic Details
Main Authors:	Judith Kooiman, Nienke van Rein, Bas Spaans, Koen A J van Beers, Jonna R Bank, Wilke R van de Peppel, Antonio Iglesias del Sol, Suzanne C Cannegieter, Ton J Rabelink, Gregory Y H Lip, Frederikus A Klok, Menno V Huisman
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24817475/pdf/?tool=EBI

Similar Items

The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment.
by: Judith Kooiman, et al.
Published: (2015-01-01)

COVID‐19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance
by: Suzanne C. Cannegieter, et al.
Published: (2020-05-01)

Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study
by: Gilda Denise Zielinski, et al.
Published: (2020-01-01)

The Viktorоvka-I settlement of the Late Archaic time
by: Denis Bondarenko
Published: (2018-11-01)

Non-VKA Oral Anticoagulants: Accurate Measurement of Plasma Drug Concentrations
by: Jonathan Douxfils, et al.
Published: (2015-01-01)

Center-Related Determinants of VKA Anticoagulation Quality: A Prospective, Multicenter Evaluation.
by: Alberto Tosetto, et al.
Published: (2015-01-01)

NOACs replace VKA as preferred oral anticoagulant among new patients: a drug utilization study in 560 pharmacies in The Netherlands
by: J. M. van den Heuvel, et al.
Published: (2018-04-01)

Higher Adherence to Treatment With Low-Molecular-Weight-Heparin Nadroparin Than Enoxaparin Because of Side Effects in Cancer-Associated Venous Thromboembolism
by: Sake J. van der Wall, et al.
Published: (2018-02-01)

Draft genome of Meyerozyma guilliermondii strain vka1: a yeast strain with composting potential
by: Ravisankar Valsalan, et al.
Published: (2020-09-01)

Computed Tomography Pulmonary Perfusion for Prediction of Short-Term Clinical Outcome in Acute Pulmonary Embolism
by: Lisette F. van Dam, et al.
Published: (2021-01-01)

Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review
by: Sake J. van der Wall, et al.
Published: (2018-11-01)

Real-world cost-effectiveness of rivaroxaban and apixaban vs VKA in stroke prevention in non-valvular atrial fibrillation in the UK
by: Kevin Bowrin, et al.
Published: (2020-01-01)

Temporal trends in initiation of VKA, rivaroxaban, apixaban and dabigatran for the treatment of venous thromboembolism - A Danish nationwide cohort study
by: Caroline Sindet-Pedersen, et al.
Published: (2017-06-01)

Cost-benefit analysis of VKA versus NOAC treatment in German patients with atrial fibrillation utilizing patient self-testing
by: Roland Diel, et al.

Self‐reported therapy adherence and predictors for nonadherence in patients who switched from vitamin K antagonists to direct oral anticoagulants
by: Myrthe M. A. Toorop, et al.
Published: (2020-05-01)

Magnetic Resonance Direct Thrombus Imaging (MRDTI) Can Distinguish Between Old and New Thrombosis in the Abdominal Aorta: a Case Report
by: Lisette Florence van Dam, et al.
Published: (2020-01-01)

Comorbidities against quality control of VKA therapy in non-valvular atrial fibrillation: a French national cross-sectional study.
by: Agnes Rouaud, et al.
Published: (2015-01-01)

Pulmonary flow profile and distensibility following acute pulmonary embolism
by: Huisman Menno V, et al.
Published: (2011-02-01)

Correction: Comorbidities against Quality Control of VKA Therapy in Non-Valvular Atrial Fibrillation: A French National Cross-Sectional Study.
by: PLOS ONE Staff
Published: (2015-01-01)

Anticoagulation in splanchnic and cerebral vein thrombosis: Still groping in the dark
by: Frederikus A. Klok, et al.
Published: (2020-10-01)

MRI evaluation of right and left ventricular remodeling and surrogate markers of PH following acute pulmonary embolism
by: Huisman Menno V, et al.
Published: (2009-01-01)

Accuracy and reproducibility of CT right-to-left ventricular diameter measurement in patients with acute pulmonary embolism.
by: Yvonne M Ende-Verhaar, et al.
Published: (2017-01-01)

Candidate Gene Analysis of Mortality in Dialysis Patients.
by: Tonia C Rothuizen, et al.
Published: (2015-01-01)

Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
by: A T Cohen, et al.
Published: (2016-01-01)

Results from the Registry of Atrial Fibrillation (AFABE): Gap between Undiagnosed and Registered Atrial Fibrillation in Adults—Ineffectiveness of Oral Anticoagulation Treatment with VKA
by: Anna Panisello-Tafalla, et al.
Published: (2015-01-01)

Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism.
by: Gudula J A M Boon, et al.
Published: (2020-01-01)

Correction: Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism.
by: Gudula J A M Boon, et al.
Published: (2020-01-01)

Diagnosing Recurrent DVT of the Leg by Two Different Non–Contrast-Enhanced Magnetic Resonance Direct Thrombus Imaging Techniques: A Pilot Study
by: Charlotte E. A. Dronkers, et al.
Published: (2019-01-01)

Correction: Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
by: A T Cohen, et al.
Published: (2016-01-01)

Regular Use of VKA Prior to COVID-19 Associated with Lower 7-Day Survival in Hospitalized Frail Elderly COVID-19 Patients: The GERIA-COVID Cohort Study
by: Pierre Ménager, et al.
Published: (2021-12-01)

Effectiveness and Safety of Apixaban for Treatment of Venous Thromboembolism in Daily Practice
by: Stephan V. Hendriks, et al.
Published: (2020-04-01)

Sensitivity of a Simple Noninvasive Screening Algorithm for Chronic Thromboembolic Pulmonary Hypertension after Acute Pulmonary Embolism
by: Yvonne M. Ende-Verhaar, et al.
Published: (2018-01-01)

Magnetic resonance thrombus imaging for the differentiation of chronic versus (sub)acute cerebral vein thrombosis: A case report
by: Lisette F. van Dam, et al.
Published: (2021-01-01)

Chest X-Ray Not Routinely Indicated Prior to the YEARS Algorithm in the Diagnostic Management of Suspected Pulmonary Embolism
by: Liselotte M. van der Pol, et al.
Published: (2019-01-01)

Left Ventricular Diastolic Dysfunction in Dialysis Patients Assessed by Novel Speckle Tracking Strain Rate Analysis: Prevalence and Determinants
by: Mihály K. de Bie, et al.
Published: (2012-01-01)

Clinical Surveillance vs. Anticoagulation For low-risk patiEnts with isolated SubSegmental Pulmonary Embolism: protocol for a multicentre randomised placebo-controlled non-inferiority trial (SAFE-SSPE)
by: Marc Carrier, et al.
Published: (2020-11-01)

Clinical Implications of Excessive Neutrophil Extracellular Trap Formation in Renal Autoimmune Diseases
by: Laura S. van Dam, et al.
Published: (2019-02-01)

Magnetic Resonance Thrombus Imaging to Differentiate Acute from Chronic Portal Vein Thrombosis
by: Lisette F. van Dam, et al.
Published: (2020-07-01)

Non-Vitamin K Oral Anticoagulants (NOAC) Versus Vitamin K Antagonists (VKA) for Atrial Fibrillation with Elective or Urgent Percutaneous Coronary Intervention: A Meta-Analysis with a Particular Focus on Combination Type
by: Ceren Eyileten, et al.
Published: (2020-04-01)

Management of Hypotension in Dialysis Patients: Role of Dialysate Temperature Control
by: van der Sande Frank, et al.
Published: (2001-01-01)